Long-term survival in an adult metastatic renal peripheral primitive neuroectodermal tumor (PPNET) with multimodality treatment including high-dose chemotherapy
Autor: | G. De Grève, R. Schots, G. Soete, A. Goossens, Christel Fontaine, J. Braeckman |
---|---|
Přispěvatelé: | Medical Imaging and Physical Sciences, Medical Oncology, Laboratory of Molecular and Medical Oncology, Vrije Universiteit Brussel, Radiation Therapy |
Rok vydání: | 1997 |
Předmět: |
Oncology
Adult Male medicine.medical_specialty Cyclophosphamide medicine.medical_treatment Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Humans Neuroectodermal Tumors Primitive Peripheral Neuroectodermal tumor Chemotherapy business.industry Peripheral Primitive Neuroectodermal Tumor Combination chemotherapy Hematology medicine.disease Chemotherapy regimen Combined Modality Therapy Kidney Neoplasms Surgery Radiation therapy Doxorubicin Vincristine Cisplatin business medicine.drug Kidney disease |
Zdroj: | Annals of oncology : official journal of the European Society for Medical Oncology. 8(7) |
ISSN: | 0923-7534 |
Popis: | We describe a 42-year-old male patient with a primitive peripheral neuroectodermal tumor (PPNET) arising from the kidney. The patient was treated sequentially with surgery, radiotherapy, experimental cytokine treatment (rhIL-6), combination chemotherapy and consolidated in complete remission with high-dose chemotherapy, supported by autologous stem cells (AST) and hematopoietic growth factors. The patient remains in complete remission at 34+ months after AST and is surviving disease-free for five years after initial presentation. The case presented here is unusual because of the renal origin and the long remission duration and survival when compared with the usual outcome of adult metastatic PPNET. High-dose chemotherapy may have favorably influenced the outcome in this patient. The case is discussed in the context of the general treatment of metastatic PPNET. |
Databáze: | OpenAIRE |
Externí odkaz: |